Metastasis from Oral Cancer: an Overview

Total Page:16

File Type:pdf, Size:1020Kb

Metastasis from Oral Cancer: an Overview CANCER GENOMICS & PROTEOMICS 9: 329-336 (2012) Review Metastasis from Oral Cancer: An Overview JULIANA NOGUTI1, CAROLINA FOOT GOMES DE MOURA1, GUSTAVO PROTASIO PACHECO DE JESUS1, VICTOR HUGO PEREIRA DA SILVA2, THAIS AYAKO HOSSAKA1, CELINA TIJUKO FUJIYAMA OSHIMA1 and DANIEL ARAKI RIBEIRO1,2 Departments of 1Pathology and 2Biosciences, Federal University of São Paulo, UNIFESP, Sao Paulo, Brazil Abstract. Oral cancer is a common neoplasm worldwide. Its surrounding tissues, with lymph node and distant metastasis, incidence and mortality have also increased over the past and a peculiarly high risk of second malignancy during the decades. It is characterized by poor prognosis and a low patient’s lifetime (1). Metastasis has been interpreted in a survival rate despite sophisticated surgical and radiotherapeutic Darwinistic perspective as being a process whereby genetic modalities. Metastasis of oral cancer is a complex process instability in the primary tumor fuels cell heterogeneity, involving detachment of cells from tumor tissue, regulation of allowing for a few metastatic clones to eventually emerge and cell motility and invasion, proliferation and evasion through the be positively selected to disseminate cancer at distance (7). It lymphatic system or blood vessels. In this review, we will focus represents the most devastating feared stage of malignancy on the current knowledge in metastasis from oral cancer and the leading cause of death from cancer. Metastasis regarding facts, such as incidence; stage, histopathology and consists of sequential and selective steps including grade of primary tumor; clinical manifestations; diagnosis; and proliferation, stimulation of angiogenesis, detachment, treatment. Certainly, such information will contribute to the motility, invasion into bloodstream and cross-talk with understanding of oral cancer pathogenesis. components of the new microenvironment, including parenchymal, stromal and inflammatory cells (8, 9). It is clear Head and neck cancer is a common neoplasm that that only a minority of malignant cells undertake the encompasses epithelial malignancies of the paranasal sinuses, metastatic route, due to an interplay between host factors and nasal cavity, pharynx and larynx, representing about 6% of intrinsic characteristics of cancer cells; thus metastasis may all cases and accounting for an estimated 650,000 new cancer represent an escape of these cells from the hostile cases and 350,000 cancer-related deaths worldwide every year environment they themselves created, such as shortage of (1, 2). Oral cancer is the most frequent type of cancer of the oxygen and nutrients, inflammation and immune system head and neck area, with squamous cell carcinoma being the attacks (10-12). This review aims to reveal recent findings, most common single entity. It may appear in any location, regarding especially oral cancer research thereby raising our although there are certain areas in which it is found more level of understanding of this crucial strategy by which cancer frequently, such as the tongue and floor of the mouth. These cells escape death, and in addition to provide new areas represent about 90% of all malignancies of the oral perspectives on oral cancer diagnosis and treatments. cavity (3, 4). However, despite significant advances in surgery and chemotherapy achieved over the past decades (5), oral Incidence cancer is still characterized by poor prognosis and a low survival rate (6). In patients diagnosed with tumors at an Oral cancer is one of the most common types of tumor in the advanced stage, there is a high occurrence of invasion to head and neck (38%) with an incidence of 75% in male patients over age 60 years old, while about 95% of cases are squamous cell carcinomas (13). Oral squamous cell carcinoma is an invasive lesion with the presence of Correspondence to: Daniel Araki Ribeiro, DDS, Ph.D., perineural growth. It has a significant recurrence rate and Departamento de Biociências, Av. Ana Costa, 95, Vila Mathias, Santos – SP, 11060-001, Brazil. Tel: +55 1332218058, Fax: +55 frequently metastasizes to cervical lymph nodes (14). Lymph 1332232592, e-mail: [email protected] node metastatic tumors occur in about 40% of patients with oral cancer. Clinically, their manifestations are hidden in rates Key Words: Oral cancer, metastasis, review. of 15% to 34% (15, 16). 1109-6535/2012 $2.00+.40 329 CANCER GENOMICS & PROTEOMICS 9: 329-336 (2012) Metastasis of oral cancer is a complex process involving The TNM classification of oral squamous cell carcinoma (33) detachment of cells from the tumor tissue, regulation of cell provides a reliable basis for patient prognosis and therapeutic motility and invasion, proliferation and evasion through the planning. There are a number of clinically detected or small lymphatic system or blood vessels. This process is due to undetectable primary tumors that display biological reduced intercellular adhesion of tumor cells as they progress aggressiveness, with early regional metastasis and death. to malignancy because of loss of E-cadherin; they thereby Typically, T1-T2 lesions are often associated with a risk of begin to express proteins such as mesenchymal vimentin and regional metastasis of 10% to 30% respectively, especially to N-cadherin, promoting cell elongation and interfering with cell lymph nodes, whereas several studies have shown a clear polarity. This morphological transition, called epithelial- correlation between increasing tumor thickness and an increased mesenchymal transition (EMT) leads to molecular alterations risk of cervical metastasis (34, 35); T3-T4 lesions have a interfering with the behavior of these cells (17). significantly higher risk of regional neck disease (13, 36). The major determinant of the prognosis of oral carcinoma is the risk of cervical metastasis. While it is widely accepted that Clinical Manifestations more advanced oral tumors be treated with elective neck dissection, management of stage I disease remains The basic procedure in checking cervical lymph nodes is controversial. In the absence of clinical neck disease, stage I physical examination (37). To facilitate treatment planning and oral cancer is often treated with primary tumor resection and to provide a sense of outcome, clinical staging is generally clinical follow-up of the neck. However, studies have shown used. The TNM clinical stage system has been adopted the incidence of occult neck metastases in stage I/II disease to worldwide. This system uses the size of the primary tumor (T), be as high as 42% (18). the extent of regional lymph node involvement (N), and the At least 50% of patients with locally-advanced head and presence of distant metastases (M) to predict prognosis (38). neck cancer develop locoregional or distant relapses, which Clinically, lymph nodes are assessed for location, number, are usually detected within the first two years of treatment size, shape, consistency, and fixation. Nodes are considered to (19). Investigators suggested that squamous cell carcinoma be malignant if their size is greater than 1 cm, and they are of the upper aerodisgetive tract with parotid metastasis most hard and fixed (39). Patients without clinical manifestations of often arises from the oral cavity or oropharynx (20, 21). It the disease are great candidates to be submitted to cervical has been postulated that unlike the parotid gland, the intervention and/or co-adjuvant therapy (40). submandibular gland is unlikely to be the host tissue for metastasis because of its lack of lymph nodes and vessels Diagnosis (22). In fact, hematogenous spread of cancer may rise from tissues outside the head and neck region (23). In addition, Auxiliary modern diagnostic modalities such as computed- unlike many other types of cancer, it characteristically tomography (CT), magnetic resonance imaging (MRI), metastasizes to the regional lymph nodes through the positron emission tomography (PET), lymphoscintigraphy draining lymphatics in the early stages (24). Lymph node (LS), ultrasonography (USG) and USG-guided fine-needle involvement is considered as the first indication for spread aspiration cytology are recommended to increase the and a strong prognostic factor (25). At present, only 25%- efficacy of the neck evaluation in patients with oral 40% of patients with lymph node metastasis will achieve 5- carcinoma, and some have become routine screening year survival, in contrast to approximately 90% of patients procedures in recent years, playing an important role in the without metastasis (26-28). According to published data, the detection of metastasis to cervical nodes (37, 41). The main incidence of occult metastases to the neck can range from advantage of CT and MRI is less inter-observer variation 15% to 60% depending on different prognostic factors (29). and these are relatively standardized techniques that can be Currently, new and highly sensitive detection methods such performed in most institutions and can be interpreted by as immunohistochemistry and molecular analysis have been radiologists without specific knowledge of images of the developed; these could be an explanation as to why the head and neck (42). Criteria such as size, laterality and rapid incidence of metastasis has even increased in the last few increase of diameter of lymph nodes are most important as years (13, 30). selection criteria for nodes to be punctured to detect occult metastasis (43). Stage, Histopathology and Grade of Primary Tumor Sentinel lymph node (SLN) status has been shown to
Recommended publications
  • Oral Cancer Fact Sheet
    Want Some Life Saving Advice? Ask Your Dental Hygienist About Oral Cancer 8/11/10 This year alone, more than 30,000 Americans will be di- • Sore throats that do not go away, or a feeling that agnosed with oral cancer and 8,000 will die of the disease. some¬ thing is caught in the throat Oral cancer is more common than leukemia, Hodgkin’s • Difficulty or pain with chewing or swallowing disease and cancers of the brain, liver, bone and stom- ach, and is typically caused by long-term use of tobacco Treatment products, alcohol and human papilloma virus (HPV) infec- As researchers continually seek out more effective tion. According to the National Cancer Institute (NCI), Oral drugs and drug combinations to help combat oral cancer, cancer is a major cause of death and disfigurement in the the most common current treatment for oral cancer, ac- United States. cording to NCI, is to remove any tumors surgically. Oral cancer also may be treated using intensive Risk Factors Approximately 75% of all oral cavity and pharyngeal cancers—mouth, tongue, lips, throat, parts of the nose Oral Cancer Self-Exam and larynx—are attributed to the use of smoked and smoke¬less tobacco, according to the Centers for Disease The following is an oral cancer self-examination that can Control and Prevention (CDC). Those who choose to use be taught to patients. cigarettes, cigars, pipes, chewing tobacco, snuff and/or bidis (cigarettes from India that come in a variety of fla- Look at and feel your: vors and contain less tobacco than regular U.S.
    [Show full text]
  • CDHO Factsheet Oral Cancer
    Disease/Medical Condition ORAL CANCER Date of Publication: August 7, 2014 (also known as “oral cavity cancer”) Is the initiation of non-invasive dental hygiene procedures* contra-indicated? Possibly (dental hygiene procedures should not be scheduled while the patient/client is experiencing oral ulcerations and pain, has an acute oral infection, has an absolute neutrophil count ≤ 1.0 X 109/L, or has a platelet count ≤ 50 X 109/L) Is medical consult advised? ..................................... Possibly (e.g., if suspicious lesion is detected; if intraoral infection and/or immunosuppression is suspected, particularly if the patient/client is undergoing radiation therapy and/or chemotherapy) Is the initiation of invasive dental hygiene procedures contra-indicated?** Possibly (contra-indicated for persons undergoing radiotherapy and/or chemotherapy for oral cancer); furthermore, dental hygiene procedures should not be scheduled while the patient/client is experiencing oral ulcerations and pain, has an acute oral infection, has an absolute neutrophil count ≤ 1000/mm3, or has a platelet count ≤ 50,000/mm3) Is medical consult advised? ...................................... See above. Is medical clearance required? .................................. Yes, if the patient/client is about to undergo or is undergoing active chemotherapy or radiation therapy for oral cancer. – Yes, if the patient/client is scheduled for major oral surgery for oral cancer. Is antibiotic prophylaxis required? ............................. No, not typically (although cancer or treatment-induced immunosuppression may warrant consideration of antibiotic prophylaxis). Is postponing treatment advised? .............................. Possibly (depends on whether cancer and its treatment may interfere with invasive procedures and whether there is immunosuppression associated with cancer treatment).1 Oral management implications Dental hygienists play an important role in early detection of oral cancer, leading to timely medical/dental referral and potential biopsy, endoscopy, and imaging.
    [Show full text]
  • Head and Neck Squamous Cell Cancer and the Human Papillomavirus
    MONOGRAPH HEAD AND NECK SQUAMOUS CELL CANCER AND THE HUMAN PAPILLOMAVIRUS: SUMMARY OF A NATIONAL CANCER INSTITUTE STATE OF THE SCIENCE MEETING, NOVEMBER 9–10, 2008, WASHINGTON, D.C. David J. Adelstein, MD,1 John A. Ridge, MD, PhD,2 Maura L. Gillison, MD, PhD,3 Anil K. Chaturvedi, PhD,4 Gypsyamber D’Souza, PhD,5 Patti E. Gravitt, PhD,5 William Westra, MD,6 Amanda Psyrri, MD, PhD,7 W. Martin Kast, PhD,8 Laura A. Koutsky, PhD,9 Anna Giuliano, PhD,10 Steven Krosnick, MD,4 Andy Trotti, MD,10 David E. Schuller, MD,3 Arlene Forastiere, MD,6 Claudio Dansky Ullmann, MD4 1 Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio. E-mail: [email protected] 2 Fox Chase Cancer Center, Philadelphia, Pennsylvania 3 Ohio State University Comprehensive Cancer Center, Columbus, Ohio 4 National Cancer Institute, Bethesda, Maryland 5 Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland 6 Johns Hopkins University School of Medicine, Baltimore, Maryland 7 Yale University School of Medicine, New Haven, Connecticut 8 University of Southern California, Los Angeles, California 9 University of Washington, Seattle, Washington 10 H. Lee Moffitt Cancer Center, Tampa, Florida Accepted 14 August 2009 Published online 29 September 2009 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/hed.21269 VC 2009 Wiley Periodicals, Inc. Head Neck 31: 1393–1422, 2009* Keywords: human papillomavirus; head and neck squamous Correspondence to: D. J. Adelstein cell cancer; state of the science Contract grant sponsor: NIH. Gypsyamber D’Souza is an advisory board member and received For the purpose of clinical trials, head and neck research funding from Merck Co.
    [Show full text]
  • Tentative Outline Special Issue for RECENT PATENTS on BIOMARKERS Oncoviruses and Oral Cancer: an Impending Facts Kiran Jadhav
    Tentative Outline Special Issue for RECENT PATENTS ON BIOMARKERS Oncoviruses and oral cancer: An impending facts Kiran Jadhav Aims & Scope: Cancer causing viruses are termed oncoviruses, and it is of interest to learn more about them.. International Agency for Research in Cancer (IARC) have termed many viruses as group I carcinogens. Viruses like human papilloma viruses (HPVs), Epstein-Barr virus (EBV), Kaposi’s sarcoma-associated herpesvirus (KSHV), hepatitis B virus (HBV) and the Merkel cell polyomavirus (MCV). Among the RNA viruses, hepatitis C virus (HCV) and the human T-cell leukemia virus type 1 (HTLV- 1)- retrovirus are associated with human malignancies. Head and neck squamous cell carcinomas (HNSCC) are the sixth most common cancers worldwide, accounting for 633000 new cases annually. The etiology of HNSCC is considered to be a multifactorial. Smoking and excessive alcohol consumption are well established risk factors for HNSCCs. Human Papilloma Virus (HPV) particularly subtype 16 has been proposed as risk factors in OSCC (Oral squamous cell carcinoma) development. Other oncogenic virus species i.e., Epstein Barr Virus and Herpes Simplex Virus Type 1 have also been proposed to be involved in oral carcinogenesis. Recent trends show that there is a decrease in incidence of oropharyngeal squamous cell carcinoma associated with the tobacco use and increase in the human papilloma virus associated with OSCC. EBV is associated with four types of cancers: Burkitt’s lymphoma (one of the most dreaded diseases in sub-Saharan Africa), Hodgkin’s lymphoma, nasopharyngeal carcinoma (the most common tumor of males in southern China), and non-Hodgkin lymphoma associated with post-transplant or HIV Immunosuppression.
    [Show full text]
  • Oral-Cancer-Facts-2020
    Oral Cancer Facts • Slightly more than 53,000 Americans will be diagnosed with oral cancer in 2020. • Worldwide the problem is much greater, with new cases exceeding 640,000 annually. • In the US, approximately 132 new individuals each day will be diagnosed with oral cancer. • The fastest growing segment of the oral/oropharyngeal cancer population comes from HPV16, a virus that goes unnoticed with no precancerous signs. • Approximately one person every hour of every day 24/7/365 will die from oral cancer in the US alone. • While not related to biology, oral cancer occurs in blacks 2 to 1 over whites. • Oral cancer occurs in men 2 to 1 over women. Risk Factors • Tobacco use in all of its forms and alcohol are major risk factors for developing oral cancer. • While the vast majority of oral cancers (front/anterior of mouth) are related to tobacco and alcohol, about 10% of these cancers come from unknown causes. This includes all three types of cancers found in the oral environment: Squamous Cell Carcinoma (SCC), Adenoid Cystic Carcinoma (ACC), and Mucoepidermoid Carcinoma (MEC). • The unknown etiology cancers may arise from a genetic aberration or frailty or from a yet unidenti- fied common shared lifestyle risk factor. Signs and Symptoms • Any sore or ulceration that does not heal within 14 days. • A red, white, or black discoloration of the soft tissues of the mouth. • Any abnormality that bleeds easily when touched (friable). • A lump or hard spot in the tissue, usually border of the tongue (induration). • Tissue raised above that which surrounds it; a growth (exophytic).
    [Show full text]
  • Ask Your Dental Hygienist About Oral Cancer
    Want Some Life Saving Advice? Ask Your Dental Hygienist About Oral Cancer This year alone, more than 30,000 Americans will be diagnosed with oral cancer and 8,000 will die of the disease. More common than leukemia, Hodgkin’s disease, and cancers of the brain, liver, bone, thyroid gland, stomach, ovaries, and cervix, oral cancer is a major cause of death and disfigurement in the United States, according to the National Cancer Institute (NCI). Risk Factors Approximately 75% of all oral cavity and pharyngeal cancers—mouth, tongue, lips, throat, parts of the nose, and larynx—are attributed to the use of smoked and smokeless tobacco, according to the Centers for Disease Control and Prevention (CDC). Those who choose to use cigarettes, cigars, pipes, chewing tobacco, snuff, and/or bidis (cigarettes from India that come in a variety of flavors and contain less tobacco than regular U.S. cigarettes, but have three times more nicotine and five times more tar) place themselves at a much higher risk of developing oral cancer and other diseases, such as heart disease and chronic obstructive pulmonary disease (COPD)—a term used to describe emphysema and chronic bronchitis. Studies also have linked chronic alcohol use to oral cancer. Researchers believe that chronic alcohol use, combined with the use of tobacco products, multiplies the risk. In addition, sun exposure is a risk factor for lip cancer. According to CDC, oral cancer occurs twice as often in males as in females. This is considerably different from the 5:1 male to female ratio of 40 years ago.
    [Show full text]
  • Human Papillomavirus and Oropharynx Cancer: Biology, Detection and Clinical Implications
    The Laryngoscope VC 2010 The American Laryngological, Rhinological and Otological Society, Inc. Contemporary Review Human Papillomavirus and Oropharynx Cancer: Biology, Detection and Clinical Implications Clint T. Allen, MD; James S. Lewis, Jr., MD; Samir K. El-Mofty, DMD, PhD; Bruce H. Haughey, MBChB; Brian Nussenbaum, MD Objectives: To review evidence for the role of tics for patients with carcinogen-associated human papillomavirus (HPV) in the etiology of oro- carcinomas. pharyngeal cancers, methods of viral detection, and Key Words: Human papillomavirus, oropharynx the resulting clinical implications. cancer, biology, detection, survival. Study Design: Contemporary review. Laryngoscope, 120:1756–1772, 2010 Methods: Published journal articles identified through PubMed and conference proceedings were reviewed. Results: HPV-associated squamous cell carcino- INTRODUCTION mas represent a distinct disease entity from carcino- Aside from a few rare causes of genetic predisposi- gen-associated squamous cell carcinomas. HPV onco- tion to develop carcinoma, the paradigm of head and proteins lead to mucosal cell transformation through neck squamous cell carcinoma (HNSCC) development well-defined mechanisms. Different methods of has centered around long-term exposure to carcinogens detecting HPV exist with variable levels of sensitivity that result in multiple insults to one or more cells at the and specificity for biologically active virus. Although 1 virus is detected in a number of head and neck sub- genetic level. These hits induce changes in the expres- sites, studies demonstrate improved outcomes in sion or function of proteins involved in cell growth, HPV-associated carcinoma of the oropharynx only. angiogenesis, replication, and cell survival, all changes The cell cycle regulatory protein p16 is upregulated that contribute to cellular transformation.1,2 However, by biologically active HPV and serves as a biomarker over the last 15 years, the incidence of HNSCC has of improved response to therapy.
    [Show full text]
  • Oral Cavity Squamous Cell Carcinoma
    Oral Cavity Squamous Cell Carcinoma Jeremy Price, MD, PhD Faculty Advisor: Yvonne Mowery, MD, PhD Duke University, Durham, NC, USA Case: History • HPI: 81F presents with left facial swelling, difficulty chewing, dentures no longer fitting, & weight loss x 3 months. 30 PY smoking hx. • PE: – ECOG: 2, dementia but independent in ADLs – HEENT: Edentulous, white left intraoral mass, exophytic and firm arising from left buccal mucosa. – Lymphatic: No cervical, submandibular, submental, or supraclavicular lymphadenopathy Common Presentations: • Oral cavity pain • Facial swelling • Dysgeusia, tongue immobility/deviation • Dysphagia • Trismus • Speech changes • Loose teeth • Poorly fitting dentures • Hx of alcohol, tobacco, betel nut use • Cranial nerve deficits: – CN V2-V3 – Trismus, impaired sensation of middle and/or lower third of face, paresthesias, impaired muscles of mastication Case: Imaging + Biopsy • CT neck w/ contrast: 4.6 x 3.2 x 3.9 cm left inner cheek heterogeneously enhancing mass eroding into the left mandible • CT chest: No metastatic disease • ENT performed incisional biopsy: well-differentiated, keratinizing invasive SCC Workup & Evaluation • H&P: complete H&N exam, FOL as clinically indicated (eg, BOT involvement), tobacco/EtOH use • CT neck with contrast and/or MRI • CT chest; consider PET systemic staging • Core or incisional bx of primary tumor vs FNA of palpable nodes; consider exam under anesthesia • Dental, speech therapy, nutrition evaluations • Multidisciplinary consultation: ENT, oral surgery, radiation oncology,
    [Show full text]
  • Oral Cancer with Special Reference to Virus Detection and Quantitative Gene Expression
    Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1179 Oral cancer with special reference to virus detection and quantitative gene expression MIRANDA SHOJAEIAN JALOULI ACTA UNIVERSITATIS UPSALIENSIS ISSN 1651-6206 ISBN 978-91-554-9476-6 UPPSALA urn:nbn:se:uu:diva-275516 2016 Dissertation presented at Uppsala University to be publicly examined in Skoog-salen, Akademiska sjukhuset, Ingång 79, Uppsala, Friday, 18 March 2016 at 09:00 for the degree of Doctor of Philosophy (Faculty of Medicine). The examination will be conducted in English. Faculty examiner: Docent Torbjörn Ramqvist. Abstract Shojaeian Jalouli, M. 2016. Oral cancer with special reference to virus detection and quantitative gene expression. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1179. 72 pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-554-9476-6. Background. Head and neck cancers (HNC) are among the most common malignancies worldwide, and about 90–92% of oral neoplasias are oral squamous cell carcinomas (OSCC). Alcohol and tobacco consumption have been recognized as the main risk factors for OSCC development. Oncogenic viruses, such as human papillomavirus (HPV) or Epstein-Barr virus (EBV), as well as genetic alterations may also contribute to tumour formation. Aims. To study the prevalence of HPV, EBV, Herpes simplex type-1 (HSV-1), and HPV-16 and their integration status as well as the molecular mechanisms that can serve as a basis for the development of OSCC. Results. In Paper I we reported a statistically significant increase in the prevalence of HPV-16 in oral epithelial dysplasia (OED) and OSCC samples compared to controls.
    [Show full text]
  • Metastatic Tumors of the Oral Cavity Review Article
    JCDP 10.5005/jp-journals-10024-1526Metastatic Tumors of the Oral Cavity REVIEW ARTICLE Metastatic Tumors of the Oral Cavity 1Roopa S Rao, 2Shankargouda Patil, 3DS Sanketh, 4N Amrutha ABSTRACT organs. Metastasis is a co-ordinated process consisting of 1,2 The pivotal reason for morbidity and mortality of any type of several discrete steps. Metastasis to the oral cavity is cancer is due to metastasis that occurs as a result of adaptation a rarity, making up only 1% of all oral malignancies and of genetically unstable cancer cells, in an ectopic conducive is associated with poor prognosis. There have been more environment. Oral metastasis in spite of being unusual or rare cases of metastasis to the jawbones than to oral soft tissues, represents around 25% of the first signs of metastatic spread. 3,4 Literature says there are more number of cases of jaw bone recorded in literature. These metastatic tumors more often 5 metastasis reported than in the oral soft tissues. The most than not turn out to be carcinomas than sarcomas. The most common primary organs metastasizing to the jaw bones and common primary sources of metastatic tumors to the oral the oral soft tissues are the breast and the lungs respectively. region are the breast, lung, kidney, bone, prostate and colon. The issue in diagnosing a metastatic tumor arises either when Diagnosing a metastatic tumor of the jaw is a real challenge the patient does not reveal the history of the primary illness he or she may be suffering from or when he or she is unaware of and its diagnosis being of utmost importance due to the it.
    [Show full text]
  • Oral Cancer in Young Adults: Report of Three Cases and Review of the Literature R
    PRACTICE oral cancer Oral cancer in young adults: report of three cases and review of the literature R. J. Oliver,1 J. Dearing,2 and I. Hindle,3 an area of leukoplakia tender to palpation. Oral cancer in young adults is fortunately uncommon in the UK. At review 1 month later the white patch had However, since it is so rare, when cases present they are often become nodular and the patient was misdiagnosed and inappropriately treated leading to delay in referred. At presentation 3 days later the definitive treatment. This may, in turn, lead to a poorer prognosis symptoms of pain from the left side of the tongue continued, exacerbated by spicy for these patients. It is debatable if oral cancer in younger adults foods but not relieved by empirical treat- carries an inherently poor prognosis and presents with more ments received from the practitioner. Intra- aggressive tumours. Three cases of oral cancer in young adults, orally, a 25 mm diameter white, verrucous aged under 30 years are presented and the literature reviewed area extended from the left lateral margin of with respect to oral cancer in this group of patients. the tongue into the sublingual area which was tender to palpation. The tissue proximal to the lesion was erythematous and atrophic ral cancer (ICD 141, 143-146) contin- We are reporting a series of cases of oral in appearance. Oues to be a serious problem in the UK cancer occurring in three apparently healthy The lesion was biopsied and histopatho- with a steadily rising incidence in certain Caucasian adult patients aged 20, 24 and 26 logical examination revealed a well differen- birth cohorts.1 Despite this, oral cancer years old who presented to one consultant tiated squamous cell carcinoma.
    [Show full text]
  • Prevention and Treatment of Oral Mucositis in Cancer Patients
    Volume 2, Issue 3, 1998 ISSN 1329 - 1874 BestPractice Evidence Based Practice Information Sheets for Health Professionals Prevention And Treatment Of Oral Mucositis In Cancer Patients Introduction This Practice Information Sheet Levels of Evidence Oral mucositis, also called Covers The Following Concepts All studies were categorised according to the strength of the evidence based on the following stomatitis, is a common, debilitating classification system. complication of cancer chemo- therapy and radiotherapy, occurring 1. Quality Of Research Level I Evidence obtained from a systematic in about 40% of patients. It results review of all relevant randomised from the systemic effects of controlled trials. Level II cytotoxic chemotherapy agents Evidence obtained from at least one and from the local effects of 2. Treatment Options properly designed randomised radiation to the oral mucosa. Oral controlled trial. Level III.1 mucositis is inflammation of the Evidence obtained from well mucosa of the mouth which ranges designed controlled trials without 3. What Is Effective randomisation. from redness to severe ulceration. Level III.2 Symptoms of mucositis vary from Evidence obtained from well designed cohort or case control pain and discomfort to an inability analytic studies preferably from more to tolerate food or fluids. Mucositis 4. Recommendations - than one centre or research group. may also limit the patient’s ability Level III.3 Oral Care Protocol Evidence obtained from multiple time to tolerate either chemotherapy or series with or without the radiotherapy. Mucositis may be so intervention. Dramatic results in uncontrolled experiments. severe as to delay treatment and Level IV so limit the effectiveness of cancer Opinion of respected authorities, therapy.
    [Show full text]